Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Envoy Medical (COCH) Operating Income (2022 - 2025)

Envoy Medical's Operating Income history spans 4 years, with the latest figure at -$5.7 million for Q3 2025.

  • For Q3 2025, Operating Income fell 14.76% year-over-year to -$5.7 million; the TTM value through Sep 2025 reached -$20.4 million, up 20.9%, while the annual FY2024 figure was -$19.3 million, 4.82% down from the prior year.
  • Operating Income for Q3 2025 was -$5.7 million at Envoy Medical, down from -$5.1 million in the prior quarter.
  • Across five years, Operating Income topped out at -$98596.0 in Q2 2023 and bottomed at -$11.1 million in Q4 2023.
  • The 4-year median for Operating Income is -$4.5 million (2024), against an average of -$4.1 million.
  • The largest annual shift saw Operating Income surged 89.06% in 2023 before it plummeted 4829.21% in 2024.
  • A 4-year view of Operating Income shows it stood at -$4.5 million in 2022, then tumbled by 145.96% to -$11.1 million in 2023, then soared by 59.08% to -$4.5 million in 2024, then dropped by 25.48% to -$5.7 million in 2025.
  • Per Business Quant, the three most recent readings for COCH's Operating Income are -$5.7 million (Q3 2025), -$5.1 million (Q2 2025), and -$5.1 million (Q1 2025).